Pre-Open Stock Movers 12/10: (CNTX) (AI) (ORCL) Higher; (ANGN) (CCNC) (MRNA) Lower (more...)

RR Donnelley (RRD) Acquired by Chatham for $10.85/sh Cash

R.R. Donnelley & Sons Company (NYSE: RRD) today announced that it has entered into a definitive merger agreement (the Chatham Merger Agreement) to be acquired by affiliates of Chatham Asset Management, LLC (Chatham), a leading private investment firm, in an all-cash transaction with a total enterprise value of approximately $2.3 billion and total equity value of approximately $897 million. RRD today also announced that it has terminated its previously announced merger agreement with affiliates of Atlas Holdings LLC (Atlas), dated November 3, 2021 (as amended on December 9, 2021, the Amended Atlas Merger Agreement), pursuant to which affiliates of Atlas had agreed to... More

Moderna (MRNA) and Australia Collaborate to Bring mRNA Manufacturing to Australia

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced an agreement in principle with the Australian Government to build a state-of-the-art messenger RNA (mRNA) vaccine manufacturing facility in Victoria, Australia including access to Modernas mRNA development engine. The contemplated framework would build the foundation to support Australia with direct access to rapid pandemic response capabilities and to provide access to Modernas vaccines in development for respiratory viruses. Moderna and the Australian government are committed to finalize the... More

Moderna's (MRNA) COVID-19 Vaccine Manufactured in Korea by Samsung Granted Marketing Authorization from Ministry of Food and Drug Safety of Korea

Moderna (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced today that the Ministry of Food and Drug Safety of Korea (MFDS) has issued a marketing authorization for Spikevax®, Moderna's COVID-19 vaccine (mRNA-1273) manufactured by Samsung Biologics, a leading global CDMO providing fully integrated end-to-end contract development and manufacturing services.

This marketing authorization obtained by Moderna Korea officially allows the Moderna's COVID-19 vaccine manufactured at Samsung Biologics' local pharmaceutical production facilities to be distributed within Korea and... More

Code Chain New Continent (CCNC) Withdraws Proposed Share Offering

Code Chain New Continent Limited (NASDAQ: CCNC), a vertically integrated cryptocurrency miner has determined that given the market conditions it is not in the best interest of the Company and its shareholders to raise equity capital at this time and intends to withdraw its previously... More

UPDATE: Chewy Inc. (CHWY) PT Lowered to $70 at Piper Sandler on Declining Margins in 2020 Due to Inflationary Headwinds

(Updated - December 13, 2021 6:57 AM EST)

Piper Sandler analyst Peter Keith lowered the price target on Chewy Inc. (NYSE: CHWY) to $70.00 (from $100.00) while maintaining an Overweight rating following results.

The analyst comments "We maintain our OW rating and lower our PT... More

Moderna (MRNA) Continues to Grind off Lows, Remains Down 5.5%

Moderna (NASDAQ: MRNA) continues to grind off lows, shares remain down 5.5%. A U.K. study that boosters give 70-75% Omicron protection is helping.

Broadcom (AVGO) trading up 9% following strong earnings, guidance, and buyback news

Broadcom (NASDAQ: AVGO) is trading up 9% following strong earnings, guidance, and buyback news.